Literature DB >> 23008138

Evidence-based surgical management of T1 or T2 temporal bone malignancies.

Ting Zhang1, Wei Li, Chunfu Dai, Fanglu Chi, Shuyi Wang, Zhengmin Wang.   

Abstract

OBJECTIVES/HYPOTHESIS: To determine whether aggressive surgical management is more effective than local canal resection (LCR) for early-stage temporal bone malignancies. STUDY
DESIGN: Retrospective study.
METHODS: Forty-three cases of early-stage external auditory canal (EAC) carcinoma who received surgical management between 1993 and 2011 were reviewed. Preoperative computed tomography, enhanced magnetic resonance imaging, pure-tone audiometry, and biopsy were performed. Patients underwent either LCR or lateral temporal bone resection (LTBR). Postoperative pathologic examinations were conducted on all specimens, including assessment of margin status. The duration of the postoperative follow-up period ranged from 6 months to 18 years.
RESULTS: Of 26 patients who underwent LCR, 10 were stage T1 and 16 were T2. Positive surgical margins were identified in 14 patients. During the follow-up, 12 patients developed recurrence. Of 17 patients who underwent LTBR with superficial parotidectomy, six were stage T1 and 11 were T2. The lateral EAC margins were negative in all 17 patients. In 2/6 T1 patients and in 5/11 T2 patients, tumor cells were identified deep within the EAC cartilage and parotid gland. All of the patients who underwent LTBR survived without evidence of recurrence.
CONCLUSIONS: LTBR with superficial parotidectomy offers the greatest chance of cure for early-stage EAC carcinoma. Intraoperative frozen sections are necessary to determine the tumor-free lateral EAC margins. Postoperative radiotherapy is not strongly recommended for early-stage EAC carcinoma after LTBR.
Copyright © 2012 The American Laryngological, Rhinological, and Otological Society, Inc.

Entities:  

Mesh:

Year:  2012        PMID: 23008138     DOI: 10.1002/lary.23637

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  14 in total

Review 1.  Temporal bone resection for lateral skull-base malignancies.

Authors:  Gautam U Mehta; Thomas J Muelleman; Derald E Brackmann; Paul W Gidley
Journal:  J Neurooncol       Date:  2020-02-27       Impact factor: 4.130

2.  Comparison of the University of Pittsburgh staging system and the eighth edition of the American Joint Committee on Cancer TNM classification for the prognostic evaluation of external auditory canal cancer.

Authors:  Shinya Morita; Takatsugu Mizumachi; Yuji Nakamaru; Tomohiro Sakashita; Satoshi Kano; Kimiko Hoshino; Atsushi Fukuda; Keishi Fujiwara; Akihiro Homma
Journal:  Int J Clin Oncol       Date:  2018-07-05       Impact factor: 3.402

3.  Temporal bone carcinoma: Classical prognostic variables revisited and modern clinico-pathological evidence.

Authors:  Elisabetta Zanoletti; Gino Marioni; Sebastiano Franchella; Sara Munari; Roberto Pareschi; Antonio Mazzoni; Alessandro Martini
Journal:  Rep Pract Oncol Radiother       Date:  2015-09-29

4.  Management of lateral skull base cancer: United Kingdom National Multidisciplinary Guidelines.

Authors:  J J Homer; T Lesser; D Moffat; N Slevin; R Price; T Blackburn
Journal:  J Laryngol Otol       Date:  2016-05       Impact factor: 1.469

5.  Multicenter experiences in temporal bone cancer surgery based on 89 cases.

Authors:  Małgorzata Wierzbicka; Kazimierz Niemczyk; Antoni Bruzgielewicz; Marcin Durko; Janusz Klatka; Tomasz Kopeć; Ewa Osuch-Wójcikiewicz; Wioletta Pietruszewska; Marcin Szymański; Witold Szyfter
Journal:  PLoS One       Date:  2017-02-22       Impact factor: 3.240

6.  Clear cell variant squamous cell carcinoma of temporal bone: Case report and literature review.

Authors:  Abdulaziz S AlEnazi; Fahad A Alwadi; Yazeed A AlOqaili
Journal:  Int J Surg Case Rep       Date:  2018-09-01

7.  Prognostic models to predict overall and cause-specific survival for patients with middle ear cancer: a population-based analysis.

Authors:  Weidong Shen; Naoko Sakamoto; Limin Yang
Journal:  BMC Cancer       Date:  2014-08-01       Impact factor: 4.430

8.  Expression profiling of long noncoding RNA identifies lnc-MMP3-1 as a prognostic biomarker in external auditory canal squamous cell carcinoma.

Authors:  Hong Liu; Chunfu Dai; Qianru Wu; Hongyan Liu; Feitian Li
Journal:  Cancer Med       Date:  2017-09-29       Impact factor: 4.452

9.  Evidence Based Tailored Parotidectomy in Treating External Auditory Canal Carcinoma.

Authors:  Jeon Mi Lee; Jin Woo Joo; Sung Huhn Kim; Jae Young Choi; In Seok Moon
Journal:  Sci Rep       Date:  2018-08-14       Impact factor: 4.379

Review 10.  Squamous cell carcinoma of the temporal bone: A current review.

Authors:  Benjamin D Lovin; Paul W Gidley
Journal:  Laryngoscope Investig Otolaryngol       Date:  2019-11-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.